Supernus Pharmaceuticals
SUPN
#4394
Rank
A$2.81 B
Marketcap
$50.36
Share price
2.78%
Change (1 day)
12.08%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.17

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.23. In 2022 the company made an earnings per share (EPS) of $1.77 an increase over its 2021 EPS that were of $1.59.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.17-33.87%
2022$1.7710.78%
2021$1.59-57.68%
2020$3.7712.09%
2019$3.360.47%
2018$3.3489.38%
2017$1.77-38.59%
2016$2.88534.48%
2015$0.45-211.54%
2014-$0.41-91.1%
2013-$4.5639.46%
2012-$3.27-69.27%
2011-$10.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$30.20 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.49 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.21 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.65 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.02 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA